AstraZeneca
-
USA
AstraZeneca maintains outlook as cancer, rare disease drugs drive profit beat
July 27 (Reuters) – AstraZeneca backed its annual and long-term forecasts on Monday after second-quarter profit expectations rose on demand…
Read More » -
USA
AstraZeneca stock dives 9% after heart drug trial misses target
shares AstraZeneca It fell as low as 9 percent after a late-stage clinical trial for an experimental heart disease treatment…
Read More » -
USA
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said AI is helping pharmaceutical manufacturers develop drugs faster and make smarter decisions throughout the research…
Read More » -
USA
AstraZeneca stock falls after FDA panel votes against new cancer drug
shares AstraZeneca It fell on Friday after U.S. regulatory advisers voted against approving the experimental cancer drug. An advisory panel…
Read More » -
USA
AstraZeneca stock jumps after surprise lung disease trial win
AstraZenecaIts shares rose nearly 5% after Britain’s most valuable company said its experimental lung disease drug had met its target…
Read More » -
USA
Airbus, AstraZeneca and HSBC executives join UK’s Starmer on high-stakes China trip
British Prime Minister Keir Starmer at Downing Street on January 27, 2026 in London, England. Jack Taylor | Getty Images…
Read More » -
USA
How AstraZeneca sealed a US medicine deal with Trump
By Maggie Fick LONDON (Reuters) – AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as…
Read More » -
UK
AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs | US healthcare
Donald Trump announced a deal with U.K.-based drugmaker AstraZeneca for a “most favored nation” drug pricing model aimed at making…
Read More » -
USA
Trump reaches drug pricing deal with AstraZeneca
U.S. President Donald Trump attends a bilateral meeting with Finnish President Alexander Stubb (not pictured) in the Oval office at…
Read More »
